TY - JOUR
T1 - Early outcomes from the Dutch Upper Gastrointestinal Cancer Audit
AU - Busweiler, L. A. D.
AU - Wijnhoven, B. P. L.
AU - van Berge Henegouwen, M. I.
AU - Henneman, D.
AU - van Grieken, N. C. T.
AU - Wouters, M. W. J. M.
AU - van Hillegersberg, R.
AU - van Sandick, J. W.
AU - AUTHOR GROUP
AU - Bosscha, K.
AU - Cats, A.
AU - Dikken, J. L.
AU - Hartgrink, H. H.
AU - de Jong, P. C.
AU - Lemmens, V. E. P. P.
AU - Nieuwenhuijzen, G. A. P.
AU - Plukker, J. T.
AU - Rosman, C.
AU - Rozema, T.
AU - Siersema, P. D.
AU - Tetteroo, G.
AU - Veldhuis, P. M. J. F.
AU - Voncken, F. E. M.
PY - 2016/12
Y1 - 2016/12
N2 - In 2011, the Dutch Upper Gastrointestinal Cancer Audit (DUCA) group began nationwide registration of all patients undergoing surgery with the intention of resection for oesophageal or gastric cancer. The aim of this study was to describe the initiation and implementation of this process along with an overview of the results. The DUCA is part of the Dutch Institute for Clinical Auditing. The audit provides (surgical) teams with reliable, weekly updated, benchmarked information on process and (case mix-adjusted) outcome measures. To accomplish this, a web-based registration was designed, based on a set of predefined quality measures. Between 2011 and 2014, a total of 2786 patients with oesophageal cancer and 1887 with gastric cancer were registered. Case ascertainment approached 100 per cent for patients registered in 2013. The percentage of patients with oesophageal cancer starting treatment within 5 weeks of diagnosis increased significantly over time from 32·5 per cent in 2011 to 41·0 per cent in 2014 (P < 0·001). The percentage of patients with a minimum of 15 examined lymph nodes in the resected specimen also increased significantly for both oesophageal cancer (from 50·3 per cent in 2011 to 73·0 per cent in 2014; P < 0·001) and gastric cancer (from 47·5 per cent in 2011 to 73·6 per cent in 2014; P < 0·001). Postoperative mortality remained stable (around 4·0 per cent) for patients with oesophageal cancer, and decreased for patients with gastric cancer (from 8·0 per cent in 2011 to 4·0 per cent in 2014; P = 0·031). Nationwide implementation of the DUCA has been successful. The results indicate a positive trend for various process and outcome measures
AB - In 2011, the Dutch Upper Gastrointestinal Cancer Audit (DUCA) group began nationwide registration of all patients undergoing surgery with the intention of resection for oesophageal or gastric cancer. The aim of this study was to describe the initiation and implementation of this process along with an overview of the results. The DUCA is part of the Dutch Institute for Clinical Auditing. The audit provides (surgical) teams with reliable, weekly updated, benchmarked information on process and (case mix-adjusted) outcome measures. To accomplish this, a web-based registration was designed, based on a set of predefined quality measures. Between 2011 and 2014, a total of 2786 patients with oesophageal cancer and 1887 with gastric cancer were registered. Case ascertainment approached 100 per cent for patients registered in 2013. The percentage of patients with oesophageal cancer starting treatment within 5 weeks of diagnosis increased significantly over time from 32·5 per cent in 2011 to 41·0 per cent in 2014 (P < 0·001). The percentage of patients with a minimum of 15 examined lymph nodes in the resected specimen also increased significantly for both oesophageal cancer (from 50·3 per cent in 2011 to 73·0 per cent in 2014; P < 0·001) and gastric cancer (from 47·5 per cent in 2011 to 73·6 per cent in 2014; P < 0·001). Postoperative mortality remained stable (around 4·0 per cent) for patients with oesophageal cancer, and decreased for patients with gastric cancer (from 8·0 per cent in 2011 to 4·0 per cent in 2014; P = 0·031). Nationwide implementation of the DUCA has been successful. The results indicate a positive trend for various process and outcome measures
U2 - https://doi.org/10.1002/bjs.10303
DO - https://doi.org/10.1002/bjs.10303
M3 - Article
C2 - 27704530
SN - 0007-1323
VL - 103
SP - 1855
EP - 1863
JO - British Journal of Surgery
JF - British Journal of Surgery
IS - 13
ER -